Invitrogen™ ELISA human PDGF-AA kit

Ref.: BL-RE-091016Manufacturer ref.: EHPDGFAX10 10 x 96 tests
€4,815.00 excl. VAT

PDGF was found to be a major mitogenic factor present in serum but absent in plasma. It is secreted by the alpha granules of the platelets, activated during blood clotting to form serum. Studies have shown...

Accession number
P04085
Dose range
41.15 to 30 000 pg/ml
Sensitivity of the dosage
40 pg/ml
Conjugate
Biotin
Product type
ELISA
Brand
Invitrogen

PDGF was found to be a major mitogenic factor present in serum but absent in plasma. It is secreted by the alpha granules of the platelets, activated during blood clotting to form serum. Studies have shown...

PDGF was found to be a major mitogenic factor present in serum but absent in plasma. It is secreted by the alpha granules of the platelets, activated during blood clotting to form serum. Studies have shown that PDGF did not correspond to one but to three molecules, each being a dimeric combination of two distinct but structurally related peptide chains called A and B. Dimeric isoforms PDGF-AA, AB, and BB are expressed differentially in various cell types and their effects are mediated by two distinct receptors, alpha and beta. There are differences in the binding of these isoforms to each receptor. In general, PDGF isoforms are potent mitogens for connective tissue cells, including dermal fibroblasts, glial cells, arterial smooth muscle cells, and certain epithelial and endothelial cells. In addition to its mitogen activity, PDGF is chemotactic for fibroblasts, smooth muscle cells and mononuclear cells. Other reported activities include stimulation of granule release by neutrophils and monocytes, facilitation of steroid synthesis by Leydig cells, stimulation of neutrophil phagocytosis, inhibition of natural killer cell activity (NK), modulation of thrombospondin expression and secretion, stimulation of collagenase activity and secretion and transient induction of T-cell secretion of IL-2, accompanied by decreasing regulation of the production of IL-4 and d-IFN-gamma, temporary effects that may allow the clone expansion of Auxiliary B and T lymphocytes activated by antigen prior to differentiation

Sensitivity

Sensitivity of the dosage: 40 pg/ml.

Measurement range

Dosing range: 41.15 to 30.000 pg/ml.

Duration of dosing

Total duration of dosing: 4 h 45 min.

Reproducibility

Coefficient of intradose variation < 10%, interdose < 12%.

Target

Target: PDGF-AA.

Technical specifications

General
BrandInvitrogen
Supplier ref. (Fisher Scientific)17787993
Specifications
Accession numberP04085
Dose range41.15 to 30 000 pg/ml
Sensitivity of the dosage40 pg/ml
ConjugateBiotin
Product typeELISA
Type of samplePlasma, Serum, Surnatant
For use with (equipment)Colorimetric microplate reader
Genetic identification (Enter)5154
Gene symbol(s)Pdgfa
Coefficient of inter-dose variation< 12%
Coefficient of intra-dose variation< 10%
Contents of kits96-well pre-coated plate, standard, dosing diluent concentrate, biotinylated detection antibody, SAV-HRP, washing pad, chromogen, stop solution, adhesive plate lids
Marker or dyeHRP
Quantity10 x 96 tests
Regulatory statusRUO
TargetPDGF-AA
Test time1 h 20 min
Physical characteristics
Volume of samplePlasma, 5 μl-Serum, 5 μl-Surnatant, 100 μl
Storage and shipping
Storage conditions2°C to 8°C
Total duration of dosing4 h 45 min

Origin and customs

Manufacturer ref.EHPDGFAX10
Country of originUnited States
HS customs code3002 12 00 00
A question or a specific configuration?
Contact us for a quote.